# Leaders Free III: BioFreedom™ Clinical Trial

> **NCT03118895** · NA · COMPLETED · sponsor: **Biosensors Europe SA** · enrollment: 404 (actual)

## Conditions studied

- Cardiac Death
- Myocardial Infarction
- Stent Thrombosis
- Bleeding
- Mortality

## Interventions

- **DEVICE:** BioFreedom™ BA9™ drug-coated stent

## Key facts

- **NCT ID:** NCT03118895
- **Lead sponsor:** Biosensors Europe SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-08
- **Primary completion:** 2019-09-05
- **Final completion:** 2022-11-18
- **Target enrollment:** 404 (ACTUAL)
- **Last updated:** 2024-02-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03118895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03118895, "Leaders Free III: BioFreedom™ Clinical Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03118895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*